Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

A Phase 3, Randomized, Multicenter, Open-Label, Crossover Study Assessing Subject Perception of Treatment Burden With Use of Weekly Growth Hormone (Somatrogon) Versus Daily Growth Hormone (Genotropin®) Injections in Children With Growth Hormone Deficiency

Category & Conditions:
Rare Diseases
Medicine:
somatrogon (PF-06836922)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
C0311002
Open Plain Language Summary Result:Click here